These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36920988)

  • 1. Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
    Yin S; Zhang F; Wu J; Lin T; Wang X
    PLoS Med; 2023 Mar; 20(3):e1004196. PubMed ID: 36920988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis.
    Chiu CY; Brumble LM; Vikram HR; Watt KD; Beam E
    Clin Transplant; 2024 Jul; 38(7):e15389. PubMed ID: 38952185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
    Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
    Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
    Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients.
    Lee J; Park JY; Huh KH; Kim BS; Kim MS; Kim SI; Ahn SH; Kim YS
    Nephrol Dial Transplant; 2017 Apr; 32(4):722-729. PubMed ID: 28339910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
    Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
    J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.
    Kim J; Chung SJ; Sinn DH; Lee KW; Park JB; Huh W; Lee JE; Jang HR; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    J Viral Hepat; 2020 Jul; 27(7):739-746. PubMed ID: 32057171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection.
    Tsai HJ; Wu MJ; Chen CH; Yang SS; Huang YH; Chang YZ; Chang HR; Lee TY
    Transpl Int; 2023; 36():11122. PubMed ID: 37125384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
    Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
    Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
    Maekawa H; Yazawa M; Koitabashi K; Imai N; Kawarazaki H; Nakazawa R; Sasaki H; Chikaraishi T; Shibagaki Y
    Transplant Proc; 2016; 48(6):2046-9. PubMed ID: 27569942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1111-1119. PubMed ID: 29845351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of HBV reactivation in leukemia patients with resolved HBV infection after allogeneic hematopoietic stem cell transplantation.
    Xiong D; Cai W; Zhao W
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102447. PubMed ID: 39181184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: A single-center experience.
    Meng C; Belino C; Pereira L; Pinho A; Sampaio S; Tavares I; Bustorff M; Sarmento A; Pestana M
    Nefrologia (Engl Ed); 2018; 38(5):545-550. PubMed ID: 29709320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta-analysis.
    Cheung CKM; Law MF; Chao DC; Wong SH; Ho R; Chao ACW; Lai JWY; Chan TYT; Tam MTK; Lau SLF; Tam THC
    J Dig Dis; 2020 Mar; 21(3):160-169. PubMed ID: 32040243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.
    Kanaan N; Kabamba B; Maréchal C; Pirson Y; Beguin C; Goffin E; Hassoun Z
    J Clin Virol; 2012 Nov; 55(3):233-8. PubMed ID: 22921412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.
    Duhart BT; Honaker MR; Shokouh-Amiri MH; Riely CA; Vera SR; Taylor SL; Al-jedai AH; Gaber AO
    Transpl Infect Dis; 2003 Sep; 5(3):126-31. PubMed ID: 14617300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
    Zappulo E; Nicolini LA; Di Grazia C; Dominietto A; Lamparelli T; Gualandi F; Caligiuri P; Bruzzone B; Angelucci E; Viscoli C; Mikulska M
    Infection; 2019 Feb; 47(1):59-65. PubMed ID: 30232604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients.
    Álvarez-López P; Riveiro-Barciela M; Oleas-Vega D; Flores-Cortes C; Román A; Perelló M; Berastegui C; Castells L; Esteban R; Buti M
    Medicine (Baltimore); 2020 Feb; 99(9):e19407. PubMed ID: 32118794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.